Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Short‑term effects of oxybutynin dosage in individuals with neurogenic bladder following spinal cord injury: A retrospective cohort study

Short‑term effects of oxybutynin dosage in individuals with neurogenic bladder following spinal cord injury: A retrospective cohort study

BIOMEDICAL REPORTS, 2024 · DOI: 10.3892/br.2024.1823 · Published: June 28, 2024

Spinal Cord InjuryUrology

Simple Explanation

This study aimed to understand how different doses of oxybutynin affect bladder pressure in people with neurogenic bladder caused by spinal cord injury. The researchers reviewed hospital records of patients with these conditions, looking at bladder pressure before and after oxybutynin treatment. The study found that a higher dose of oxybutynin was linked to a lower bladder pressure, suggesting the drug is effective for managing this condition.

Study Duration
January 1999 and December 2016
Participants
245 participants (112 who received no medication and 133 treated with oxybutynin)
Evidence Level
Retrospective cohort study

Key Findings

  • 1
    Each 1 mg increase in oxybutynin dosage was associated with a mean decrease of 0.9 cmH2O in detrusor pressure.
  • 2
    In patients with indwelling catheters, a 1 mg dose of oxybutynin was associated with a mean decrease in detrusor pressure of 0.5 cmH2O.
  • 3
    In patients using clean intermittent catheterization, a 1 mg dose of oxybutynin was associated with a mean decrease in detrusor pressure of 1.0 cmH2O.

Research Summary

This study investigated the dose-response relationship of oxybutynin in reducing detrusor pressure (Pdet) in individuals with neurogenic bladder (NGB) following spinal cord injury (SCI). The study found that each 1 mg increase in oxybutynin dosage was associated with a decrease of 0.9 cmH2O in Pdet, indicating a dose-response relationship. The study also stratified patients by bladder management methods, revealing that patients with indwelling catheters responded less to oxybutynin compared to those without indwelling catheters.

Practical Implications

Dosage Guidance

The study provides guidance for setting the starting dose of oxybutynin in patients with NGB and SCI.

Personalized Treatment

Physicians can adjust the optimal dosage of oxybutynin based on individual detrusor pressure and bladder management methods.

Clinical Effectiveness

Oxybutynin is clinically effective for managing NGB in patients with SCI.

Study Limitations

  • 1
    Retrospective study design may introduce selection bias.
  • 2
    Incomplete records and patients lost to follow-up may compromise generalizability.
  • 3
    No data regarding compliance for medications and medical adverse effects.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury